Cardiovascular Disease in Diabetics: Pharmacology and Revascularization

Simple item page
dc.contributor.authorMangalmurti, Sarang S
dc.contributor.authorFarkouh, Michael E
dc.date.accessioned2019-08-14T14:58:53Z
dc.date.available2019-08-14T14:58:53Z
dc.date.issued2004
dc.description.abstractDiabetes has become a public health crisis. With the incidence of obesity rising in the United States, the number of diabetics will grow considerably. Of greatest concern is the impact this trend will have on cardiovascular disease. Diabetics demonstrate accelerated coronary atherosclerosis, and the prognosis is worse following cardiac events. Moreover, our interventions have achieved uneven success in treating this subset of patients. This paper will review the metabolic abnormalities that promote atherosclerosis in diabetics and the current methods for treating and preventing the development of coronary artery disease in diabetics, principally through a combination of medications and revascularization.
dc.identifierhttps://doi.org/10.13016/snc0-69gn
dc.identifier.citationMangalmurti, Sarang S and Farkouh, Michael E (2004) Cardiovascular Disease in Diabetics: Pharmacology and Revascularization. The Mount Sinai Journal of Medicine, 71 (6). pp. 375-383.
dc.identifier.otherEprint ID 280
dc.identifier.urihttp://hdl.handle.net/1903/22451
dc.subjectHealth
dc.subjectDiabetes
dc.subjectcardiovascular disease
dc.subjectinsulin resistance
dc.subjectantiplatelet
dc.subjectdyslipidemia
dc.subjecthypertension
dc.subjectmyocardial infarction
dc.subjectacute coronary syndrome
dc.subjectrevascularization
dc.titleCardiovascular Disease in Diabetics: Pharmacology and Revascularization
dc.typeArticle

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Cardiovascular_Disease_in_Diabetics-_Pharmacology_and_Revascularization.pdf
Size:
154.64 KB
Format:
Adobe Portable Document Format
Download

Collections

Minority Health and Health Equity Archive